2020
DOI: 10.1007/s11886-020-01379-x
|View full text |Cite
|
Sign up to set email alerts
|

The Imaging Toolbox to Assess Patients with Suspected Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease (MINOCA)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0
4

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 8 publications
(15 citation statements)
references
References 22 publications
0
11
0
4
Order By: Relevance
“…Current guidelines recommend medical treatment of plaque rupture with MINOCA in a similar manner to plaque rupture with obstructive coronary artery diseaese [ 9 ]. Therefore, for patients with confirmed plaque disruption and MINOCA, dual antiplatelet therapy can be prescribed for 1 year followed by lifetime single antiplatelet therapy.…”
Section: A Review Of Minoca Etiologiesmentioning
confidence: 99%
See 1 more Smart Citation
“…Current guidelines recommend medical treatment of plaque rupture with MINOCA in a similar manner to plaque rupture with obstructive coronary artery diseaese [ 9 ]. Therefore, for patients with confirmed plaque disruption and MINOCA, dual antiplatelet therapy can be prescribed for 1 year followed by lifetime single antiplatelet therapy.…”
Section: A Review Of Minoca Etiologiesmentioning
confidence: 99%
“…To define the underlying cause, scientific statements and guidelines recommend multimodality imaging in MINOCA [ 2 ••, 7 , 8 ]. A recent review [ 9 ] highlights the importance of such imaging to uncover all cases of MINOCA. In the current paper, we review the major coronary etiologies of MINOCA, highlight newer data supporting multimodality imaging in patients with suspected MINOCA, and provide some case examples.…”
Section: Introductionmentioning
confidence: 99%
“…CMR is a particularly important diagnostic tool when MINOCA is suspected [ 53 ]. CMR has emerged as the gold standard for noninvasive assessment of the heart due to its safety, accuracy, ability to characterize the myocardium, and inter-observer consistency.…”
Section: Minoca Work-up and Clinical Treatment Regimensmentioning
confidence: 99%
“…CMRI can exclude myocarditis, nonspecific cardiomyopathies, and takotsubo cardiomyopathy. 27 Further, CMRI provides the ability to confirm imaging evidence of AMI. The presence of myocardial edema on T2-weighted imaging can identify recent MI or myocarditis.…”
Section: Diagnostic Evaluationmentioning
confidence: 99%
“…The AHA has also emphasized on the importance of treating CAD risk factors, such as smoking, diabetes mellitus, hypertension, and hyperlipidemia to reduce risk for future events. 27 Currently, there are no randomized trials addressing the use of empiric cardioprotective medications in all patients presenting with MINOCA during the index hospitalization. Data published from the SWEDEHEART registry was the first large observational study to show benefits in utilizing secondary cardioprotective strategies such as an ACEI/ARB, statins, BB, and DAPT for the treatment of MINOCA.…”
Section: Secondary Cardioprotective Therapiesmentioning
confidence: 99%